Nitric oxide protects against microcirculatory complications of malaria
一氧化氮可预防疟疾的微循环并发症
基本信息
- 批准号:7837444
- 负责人:
- 金额:$ 34.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2011-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdhesionsAnimalsApoptosisArginineArtsAtherosclerosisBiological AssayBiological AvailabilityBloodBlood - brain barrier anatomyBlood PlateletsBlood PressureBlood SubstitutesBlood VesselsBlood capillariesBlood flowBrainCell AdhesionCell Adhesion MoleculesCellsCerebral MalariaCessation of lifeChildComplexCyclic GMPDataDevelopmentDiseaseDoctor of PhilosophyDyesE-SelectinElectrodesEndothelial CellsErythrocytesEvans blue stainExhibitsExtravasationFunctional disorderGenerationsHemoglobinHemorrhageHypotensionHypoxiaICAM1 geneImpaired cognitionInfectionInflammationLactic AcidosisLeadLeukocytesLocationMalariaMalignant NeoplasmsMeasurementMeasuresMediatingMicrocirculationMicrovascular PermeabilityMolecularMusNBL1 geneNecrosisNitric OxideNitric Oxide DonorsOrgan failureOxygenParasite ControlParasitemiaParasitesPathogenesisPatientsPerfusionPermeabilityPlasmodium bergheiProductionProteinsRadiolabeledReperfusion InjuryResearchResearch PersonnelRoleSalineSepsisShockSickle Cell AnemiaSignal TransductionStrokeSuperoxidesTechniquesTissuesToxic effectVascular Endothelial Growth FactorsVascular PermeabilitiesVenousarteriolebasebrain tissuecapillarydensityin vivoinsightintravital microscopykillingslight microscopyomega-N-Methylargininepreventprogramsradiotracerresponsetissue oxygenationvasoconstrictionvenule
项目摘要
We propose that low nitric oxide (NO) bioavailability mediates the microcirculatory complications of
severe malaria; NO quenching by cell-free hemoglobin (Hb) released as an unavoidable consequence of
parasite replication and low NO production due to hypoargininemia lead to low NO bioavailability. Vascular
eak, petechial hemorrhaging, and hypotension are well recognized complications of experimental cerebral
malaria (ECM), and the proposed studies will determine whether poor tissue oxygenation also functions in
malaria pathogenesis by altering blood flow or functional capillary density. Our observations that (i) free
hemoglobin (Hb) is markedly elevated during ECM, (ii) free Hb scavenges nitric oxide (NO) and (iii)marked
hypoargininemia occurs during ECM indicate that, in contrast to sepsis, malaria shock is caused by low NO
bioavailability. A major controversy in microcirculation research is the role of NO in mediating vascular leak
and pathogenesis, and our proposed studies will define its role in vascular leak during ECM.
A key prediction of our hypothesis is that exogenous NO should protect against ECM pathogenesis;
indeed, NO donor administration significantly (P=0.003) protects animals from the development of disease.
The markedly protected NO donor-treated mice abrogated the vascular leak, petechial hemorrhage,
hypotension, and impaired NO mediated signaling (cGMP levels) that were detected in saline-injected
controls with ECM. These studies will be extended to define whether NO donor administration protects
against other microcirculatory dysfunction during ECM, such as low tissue perfusion and oxygenation (aim
1). Adhesion of parasitized erythrocytes (pRBCs), platelets, and leukocytes occur during ECM and
deficiency of selected cell adhesion molecules protects against malaria pathogenesis. We will inter relate
the results of the microcirculatory complications of ECM to cell adhesion and eCAM expression to define the
cellular and molecular mechanisms whereby cell adhesion contributes to disruption of the blood brain barrier
and pathogenesis and identify whether and how exogenous NO protects against ECM cell adhesion (aim 2).
The final aim will assess by bioassay (arteriolar dilation, and venular leak) and actual measurement (NO
electrode) whether NO bioavailability is impaired during ECM and restored by the protective NO donor. The
response of eNOS to ECM and NO donor treatment will also be elucidated; a detailed understanding of in
vivo eNOS responses to free Hb or to low NO bioavailability that occurs during other diseases (sickle cell
anemia) is currently lacking. Besides providing new information about the microcirculation, the proposed
studies may lead to adjunct therapy for malaria that rescues millions of children from death or impaired
cognition. These studies will also address long standing controversies about malaria pathogenesis, such as
whether pRBC adhesion leads to hypoxia and multi-organ failure (sequestration hypothesis).
我们认为低一氧化氮(NO)的生物利用度介导的微循环并发症
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Leonardo Jose de Moura Carvalho其他文献
Leonardo Jose de Moura Carvalho的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Leonardo Jose de Moura Carvalho', 18)}}的其他基金
Nitric Oxide Restoration & Heme Detoxification as Adjunctive Therapies for Cerebr
一氧化氮恢复
- 批准号:
8311681 - 财政年份:2009
- 资助金额:
$ 34.02万 - 项目类别:
Nitric Oxide Restoration & Heme Detoxification as Adjunctive Therapies for Cerebr
一氧化氮恢复
- 批准号:
7658650 - 财政年份:2009
- 资助金额:
$ 34.02万 - 项目类别:
Nitric Oxide Restoration & Heme Detoxification as Adjunctive Therapies for Cerebr
一氧化氮恢复
- 批准号:
8126272 - 财政年份:2009
- 资助金额:
$ 34.02万 - 项目类别:
Nitric Oxide Restoration & Heme Detoxification as Adjunctive Therapies for Cerebr
一氧化氮恢复
- 批准号:
7928776 - 财政年份:2009
- 资助金额:
$ 34.02万 - 项目类别:
Improving transcapillary transport by reducing interstitial fluid pressure
通过降低间质液压力改善跨毛细血管运输
- 批准号:
7608616 - 财政年份:2008
- 资助金额:
$ 34.02万 - 项目类别:
Nitric oxide protects against microcirculatory complications of malaria
一氧化氮可预防疟疾的微循环并发症
- 批准号:
7393113 - 财政年份:2007
- 资助金额:
$ 34.02万 - 项目类别:
Nitric oxide protects against microcirculatory complications of malaria
一氧化氮可预防疟疾的微循环并发症
- 批准号:
7192080 - 财政年份:2007
- 资助金额:
$ 34.02万 - 项目类别:
Nitric oxide protects against microcirculatory complications of malaria
一氧化氮可预防疟疾的微循环并发症
- 批准号:
7596233 - 财政年份:2007
- 资助金额:
$ 34.02万 - 项目类别:
Nitric oxide protects against microcirculatory complications of malaria
一氧化氮可预防疟疾的微循环并发症
- 批准号:
7845632 - 财政年份:2007
- 资助金额:
$ 34.02万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 34.02万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 34.02万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 34.02万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 34.02万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 34.02万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 34.02万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 34.02万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 34.02万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 34.02万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 34.02万 - 项目类别:














{{item.name}}会员




